Switching tracks: activity of entrectinib after progression while on larotrectinib in neurotrophin receptor tyrosine kinase-fused pediatric high-grade CNS tumors
Salvato in:
| Autori principali: | , , , , , , , , , , , |
|---|---|
| Natura: | Other |
| Lingua: | inglese |
| Pubblicazione: |
May 14, 2026
|
| In: |
JCO precision oncology
Year: 2026, Volume: 10, Fascicolo: 5, Pages: 1-8 |
| ISSN: | 2473-4284 |
| DOI: | 10.1200/PO-26-00022 |
| Accesso online: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/PO-26-00022 |
| Note sull'autore: | Emily C. Hardin, MD; Sebastian Stark, MD; Claudia Zinke, MD; Inga Harting, MD ; Kristian W. Pajtler, MD, MB; Florian Selt, MD; Till Milde, MD, MHBA; Laura Fankhauser, MD; Stefan M. Pfister, MD; Olaf Witt, MD; Ute K. Bartels, MD, PhD, MSc; and Cornelis M. van Tilburg, MD, PhD |
| Descrizione del documento: | Gesehen am 17.09.2026 |
|---|---|
| ISSN: | 2473-4284 |
| DOI: | 10.1200/PO-26-00022 |